Ashwin Patel: Evaluating Red Cell Function Post-Treatment in SCD Patients
Ashwin Patel, Assistant Professor at Emory University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Advances, adding:
“It is my pleasure to share our team’s article published in the journal ‘Blood Advances’.
In this multicenter study, we evaluated red cell function in patients with sickle cell disease (SCD) who were treated with gene therapy, stem cell transplantation, or hydroxyurea.
Unlike conventional laboratory tests, red cell function tests – deformability test, blood viscosity, and dense RBCs—provide additional information.
Patients with SCD have less deformable, rigid RBCs that cannot change their shape to flow through small blood vessels, thus obstructing them and causing pain crises.
SCD patients also have high blood viscosity and dense RBCs (higher hemoglobin per RBC) compared to normal individuals.
We show abnormal red cell function post-gene therapy and post-transplantation despite adequate myeloid chimerism.”
Title: Blood Rheology After Allogeneic Hematopoietic Stem Cell Transplantation or Gene Therapy in Sickle Cell Disease
Authors: Ashwin P Patel, Tami D. John, Stephen Gottschalk, Brandon M. Triplett, Serena De Vita, Elizabeth O Stenger, Akshay Sharma, Vivien A Sheehan

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 9, 2026, 09:29Michael Wilkinson: How Lp(a) Shapes Coronary Plaque and Cardiovascular Risk
-
Aug 9, 2026, 09:16Preparing for Gene Therapy Starts with Understanding Immunity – WFH
-
Aug 9, 2026, 08:46Christina Pohlman: Uncovering the Autoantibodies Behind APS
-
Aug 9, 2026, 08:39Alejandro González Veliz: The Future of Cardiogenic Shock Lies in Precision Medicine
-
Aug 9, 2026, 08:29Heba Youssef: Off-Label Doesn’t Mean Off-Guidelines
-
Aug 9, 2026, 08:18Fawaz AlOtaibi: Why Experts Are Challenging the New Stroke Guideline
-
Aug 9, 2026, 08:08Jason Carney: Addressing the National Blood Shortage Through AI-Driven Patient Blood Management
-
Aug 9, 2026, 07:54Hamdy Alkady: FDA Approves the First Oral PCSK9 Inhibitor
-
Aug 9, 2026, 07:51Mostafa Hammam: Antibody Panels in Blood Bank Feeling Like a Chaotic Puzzle? Here is How to Master the Grid